The impact of concurrent HPV infections on the presentation of high grade cervical intraepithelial lesions

• Published in: Ginekologia polska 2020-01, Vol.91 (6), p.324-330
• Main Authors: Ozturk, Emine, Ince, Onur, Karaca, İbrahim, Demirayak, Gokhan, Comba, Cihan, Alay, Ismail, Erdogan, Volkan Sakir, Yıldırım Karaca, Suna, Ozdemir, Isa Aykut
• Format: Article
• Language: English
• Subjects: Cervical cancer; Human papillomavirus; Infections; Medical screening
• ISSN: 0017-0011; 2543-6767
• DOI: 10.5603/GP.a2020.0002

OBJECTIVES: We investigate how concurrent high-risk (hr) HPV (human papillomavirus) genotypes affect CIN2-3 risk and evaluate the relationship of different genotype combinations with cervical epithelial lesions. MATERIAL AND METHODS: This study included HPV positive patients between the ages of 30 and 60 who underwent liquid-based cervical smears and HPV screening through community-based, cervical cancer screening programs between June 2015 and June 2017. The impact of the increase in hrHPV types was calculated by estimating how it changed the odds ratio of CIN2-3 risk. RESULTS: The rate of multiple concurrent HPV infections was 48.7% in the CIN2-3 group and 58.4% in the CIN1 group. Among patients in the CIN2-3 and CIN1 groups, the most common HPV coinfection was respectively HPV 16+31 and HPV 16+51. The HPV 51 ratio in CIN1 patients was 28.9% and the HPV 51 ratio in the CIN2-3 patient was 6.6%. With every increase in the number of hrHPV infection types, the frequency of CIN2-3 decreased [OR: 0.72, 95% CI: 0.54-0.95]. For all hrHPV combinations, the addition of HPV 16 was associated with a higher risk of CIN2-3. CONCLUSIONS: An increase in number of hrHPV types is associated with lower CIN2-3 risk. Further cohort studies with larger samples are needed to clarify this relationship. The available evidence suggests that HPV 16 genotype plays an important role in patients with high-grade cervical lesions and has a negative impact on the cervix in concurrent multiple HPV infections.